John Wiley & Sons : Asthma Medication May Have Psychiatric Side Effects
September 20, 2017 at 12:15 am EDT
Share
In a Pharmacology Research & Perspectives study, the asthma medication montelukast (trade name Singulair) was linked with neuropsychiatric reactions such as depression and aggression, with nightmares being especially frequent in children.
For the study, investigators examined all adverse drug reactions on montelukast in children and adults reported to the Netherlands Pharmacovigilance Center Lareb and the WHO Global database, VigiBase®, until 2016.
'Because of the high incidence of neuropsychiatric symptoms-especially nightmares-after using montelukast in both children and adults, the clinician should discuss the possibility of these adverse events with the patient and parents,' said Meindina Haarman, lead author of the study.
Additional Information
Link to Study: http://doi.wiley.com/10.1002/prp2.341
About Journal
Pharmacology Research & Perspectives (PR&P) is a collaboration between the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS) and Wiley. PR&P is an open access journal that publishes original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, education and related research areas.
John Wiley & Sons Inc. published this content on 20 September 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 20 September 2017 04:14:05 UTC.
Original documenthttp://newsroom.wiley.com/press-release/pharmacology-research-perspectives/asthma-medication-may-have-psychiatric-side-effects
Public permalinkhttp://www.publicnow.com/view/8E3CC5A6ABB2F65E9BEA4B6982F688BEAA33CA73
John Wiley & Sons, Inc. is a knowledge company. The Company is engaged in providing research, publishing, and knowledge solutions. The Company's segments include Research, Learning, and Held for Sale or Sold. Research segment is a provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. The Company's Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers, and other professionals.
JOHN WILEY & SONS, INC. 
